Want to join the conversation?
$IFF 2Q15 Q&A: Lieberman of Barclays Capital asked to bridge gap between reported sales being down and EBIT being up for incentive comp. Alison answered that it's a combination of incentive comp. Raw materials are down, productivity savings are up. Those are the main drivers.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?